HCPCS Code Details - J9217

HCPCS Level II Code
Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J9217
Description

Long description:
Leuprolide acetate (for depot suspension), 7.5 mg

Short description:
Leuprolide acetate suspnsion

HCPCS Modifier1
HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code D - Special coverage instructions apply
ASC payment group code Effective Jan 01, 2008 - This procedure is approved to be performed in an ambulatory surgical center.
BETOS2 code O1D - Chemotherapy
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jan 01, 1997
Date added Added Jan 01, 1991
HCPCS Coding Procedures

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
NU” identifies the hospital bed as new equipment

ASP Drug pricing - J9217

Effective Code Dosage Payment
Limit
Vaccine AWP % Vaccine Limit Infusion AWP % DME infusion limit Blood AWP % Blood limit Clotting factor Note
October 1, 2024 - December 31, 2024 7.5 MG 176.51 - - - - - -
Jul 1, 2024 - Sep 30, 2024 7.5 MG 180.54 - - - - - -
April 1, 2024 - June 30, 2024 7.5 MG 185.662 - - - - - -
January 1, 2024 - March 31, 2024 7.5 MG 181.302 - - - - - -
October 1, 2023 - December 31, 2023 7.5 MG 166.685 20% - - - - -

See also

  • HCPCS J9216 · Injection, interferon, gamma 1-b, 3 million units

  • HCPCS J9218 · Leuprolide acetate, per 1 mg


1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”